Improving the adherence to antiretroviral therapy, a difficult but essential task for a successful HIV treatment—clinical points of view and practical considerations

SA Iacob, DG Iacob, G Jugulete - Frontiers in pharmacology, 2017 - frontiersin.org
HIV infection is responsible for one the most devastating human pandemics. The advent of
antiretroviral therapy has changed the course of the pandemic and saved millions of lives …

Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa

N Croome, M Ahluwalia, LD Hughes, M Abas - Aids, 2017 - journals.lww.com
Objective: The aim of this study was to identify the range and frequency of patient-reported
barriers and facilitators to antiretroviral treatment (ART) adherence in sub-Saharan Africa …

Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review

O Omonaiye, S Kusljic, P Nicholson, E Manias - BMC public health, 2018 - Springer
Background The use of antiretroviral therapy (ART) is a core strategy proposed by the World
Health Organization in preventing mother to child transmission (MTCT) of HIV. This …

Factors associated with loss to follow‐up among women in Option B+ PMTCT programme in northeast Ethiopia: a retrospective cohort study

I Mitiku, M Arefayne, Y Mesfin… - African Journal of …, 2016 - journals.lww.com
Introduction: Ethiopia has recently adopted lifelong antiretroviral therapy (ART) for all HIV-
positive pregnant and breastfeeding women (Option B'strategy), regardless of CD4 count or …

Adherence to option B+ antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta …

LC Fassinou, D Songwa Nkeunang, T Delvaux… - BMC public health, 2024 - Springer
Background To assess the adherence to option B+ antiretroviral therapy (ART) and
associated factors in pregnant and breastfeeding women in Sub-Saharan Africa (SSA) …

Implementation effectiveness of revised (post-2010) World Health Organization guidelines on prevention of mother-to-child transmission of HIV using routinely …

S Gumede-Moyo, S Filteau, T Munthali, J Todd… - Medicine, 2017 - journals.lww.com
Background: To synthesize and evaluate the impact of implementing post-2010 World
Health Organization (WHO) prevention of mother-to-child transmission (PMTCT) guidelines …

Retention of HIV infected pregnant and breastfeeding women on option B+ in Gomba District, Uganda: a retrospective cohort study

G Kiwanuka, N Kiwanuka, F Muneza, J Nabirye… - BMC infectious …, 2018 - Springer
Background Lifelong antiretroviral therapy for HIV infected pregnant and lactating women
(Option B+) has been rapidly scaled up but there are concerns about poor retention of …

Understanding women's uptake and adherence in option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: a qualitative study

C Lumbantoruan, M Kermode, A Giyai, A Ang… - PloS one, 2018 - journals.plos.org
Background Despite a more proactive approach to reducing new HIV infections in infants
through lifelong treatment (Option B+ policy) for infected pregnant women, prevention of …

Prevalence of depression among HIV-positive pregnant women and its association with adherence to antiretroviral therapy in Addis Ababa, Ethiopia

W Abebe, M Gebremariam, M Molla, S Teferra… - PloS one, 2022 - journals.plos.org
Background Vertical transmission of HIV remains one of the most common transmission
modes. Antiretroviral therapy (ART) decreases the risk of transmission to less than 2%, but …

Exploring factors associated with ART adherence and retention in care under Option B+ strategy in Malawi: A qualitative study

S Gugsa, K Potter, H Tweya, S Phiri, O Sande… - PloS one, 2017 - journals.plos.org
Although several studies have documented challenges related to inadequate adherence to
antiretroviral therapy (ART) and high loss to follow-up (LTFU) among Option B+ women …